Bone marrow fibrosis in thrombopoietin treated patients-biochemical markers and mechanisms
Fibroproliferative activity in patients with immune thrombocytopenia (ITP) treated with thrombopoietic agents.
Br J Haematol 2011 Oct;155(2):248-55. Epub 2011 sep 9
Thrombopoietin receptor agonist therapy in primary immune thrombocytopenia is associated with bone marrow hypercellularity and m